Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRAFV600E promotes anchorage-independent growth but inhibits anchorage-dependent growth in hTERT/Cdk4-Immortalized normal human bronchial epithelial cells.
Muraki N, Kawabe N, Ohashi A, Umeda K, Katsuda M, Tomatsu A, Yoshida M, Komeda K, Minna JD, Tanaka I, Morise M, Matsushima M, Matsui Y, Kawabe T, Sato M. Muraki N, et al. Among authors: kawabe n. Exp Cell Res. 2024 Apr 26;439(1):114057. doi: 10.1016/j.yexcr.2024.114057. Online ahead of print. Exp Cell Res. 2024. PMID: 38679315
Silencing of GRHL2 induces epithelial‑to‑mesenchymal transition in lung cancer cell lines with different effects on proliferation and clonogenic growth.
Kawabe N, Matsuoka K, Komeda K, Muraki N, Takaba M, Togami Y, Ito Y, Yamada M, Sunaga N, Girard L, Minna JD, Cai L, Xie Y, Tanaka I, Morise M, Sato M. Kawabe N, et al. Oncol Lett. 2023 Jul 25;26(3):391. doi: 10.3892/ol.2023.13977. eCollection 2023 Sep. Oncol Lett. 2023. PMID: 37600329 Free PMC article.
Effect of Early Rehabilitation on Walking Independence and Health-Related Quality of Life in Patients With Chronic Foot Wounds: A Multicenter Randomized Clinical Trial.
Maeshige N, Hayashi H, Kawabe N, Imaoka S, Sakaki S, Matsumoto J, Kondo E, Ishii T, Kiyota N, Furukawa M, Terashi H, Sonoda Y. Maeshige N, et al. Among authors: kawabe n. Int J Low Extrem Wounds. 2023 Jul 13:15347346231187178. doi: 10.1177/15347346231187178. Online ahead of print. Int J Low Extrem Wounds. 2023. PMID: 37448201
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
Clinical Outcomes of Cabozantinib in Patients Previously Treated with Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma-Importance of Good Liver Function and Good Performance Status.
Kuzuya T, Kawabe N, Ariga M, Ohno E, Funasaka K, Nagasaka M, Nakagawa Y, Miyahara R, Shibata T, Takahara T, Kato Y, Hirooka Y. Kuzuya T, et al. Among authors: kawabe n. Cancers (Basel). 2023 May 28;15(11):2952. doi: 10.3390/cancers15112952. Cancers (Basel). 2023. PMID: 37296914 Free PMC article.
126 results